BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 28580827)

  • 21. Recent developments in the diagnosis and treatment of pulmonary embolism.
    van der Hulle T; Dronkers CE; Klok FA; Huisman MV
    J Intern Med; 2016 Jan; 279(1):16-29. PubMed ID: 26286356
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of patients with acute deep vein thrombosis and/or pulmonary embolism: efficacy and safety of non-VKA oral anticoagulants in selected populations.
    Prandoni P
    Thromb Res; 2014 Aug; 134(2):227-33. PubMed ID: 24875390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of acute pulmonary embolism as outpatients or following early discharge. A systematic review.
    Janjua M; Badshah A; Matta F; Danescu LG; Yaekoub AY; Stein PD
    Thromb Haemost; 2008 Nov; 100(5):756-61. PubMed ID: 18989517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of venous thromboembolism.
    Wells PS; Forgie MA; Rodger MA
    JAMA; 2014 Feb; 311(7):717-28. PubMed ID: 24549552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prescription patterns of direct oral anticoagulants in pulmonary embolism: A prospective multicenter French registry.
    Chopard R; Andarelli JN; Humbert S; Falvo N; Morel-Aleton M; Bonnet B; Napporn G; Kalbacher E; Obert L; Degano B; Cappelier G; Cottin Y; Schiele F; Meneveau N
    Thromb Res; 2019 Feb; 174():27-33. PubMed ID: 30553162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New direct oral oral anticoagulants (DOACs) - indications of DOACs].
    Darius H
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2014 Mar; 49(3):182-90; quiz 191. PubMed ID: 24711238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Editor's Choice - efficacy and safety of the new oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban in the treatment and secondary prevention of venous thromboembolism: a systematic review and meta-analysis of phase III trials.
    Kakkos SK; Kirkilesis GI; Tsolakis IA
    Eur J Vasc Endovasc Surg; 2014 Nov; 48(5):565-75. PubMed ID: 24951377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute pulmonary embolism. Part 2: treatment.
    van Es J; Douma RA; Gerdes VE; Kamphuisen PW; Büller HR
    Nat Rev Cardiol; 2010 Nov; 7(11):613-22. PubMed ID: 20842179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylaxis against venous thromboembolism in hospitalized medical patients: an evidence-based and practical approach.
    Douketis JD; Moinuddin I
    Pol Arch Med Wewn; 2008 Apr; 118(4):209-15. PubMed ID: 18575420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of Pulmonary Embolism: An Update.
    Konstantinides SV; Barco S; Lankeit M; Meyer G
    J Am Coll Cardiol; 2016 Mar; 67(8):976-990. PubMed ID: 26916489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Best Clinical Practice: Controversies in Outpatient Management of Acute Pulmonary Embolism.
    Long B; Koyfman A
    J Emerg Med; 2017 May; 52(5):668-679. PubMed ID: 28007362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RE-COVERY DVT/PE: Rationale and design of a prospective observational study of acute venous thromboembolism with a focus on dabigatran etexilate.
    Ageno W; Casella IB; Han CK; Raskob GE; Schellong S; Schulman S; Singer DE; Kimura K; Tang W; Desch M; Goldhaber SZ
    Thromb Haemost; 2017 Jan; 117(2):415-421. PubMed ID: 27853808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Venous thromboembolism: contemporary diagnostic and therapeutic aspects.
    Bounameaux H; Righini M; Perrier A
    Vasa; 2008 Aug; 37(3):211-26. PubMed ID: 18690588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential benefit risk assessment of DOACs in the treatment of venous thromboembolism: focus on dabigatran.
    Leung TS; Law EH
    Drug Des Devel Ther; 2015; 9():3557-69. PubMed ID: 26185422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism: The PADIS-PE Randomized Clinical Trial.
    Couturaud F; Sanchez O; Pernod G; Mismetti P; Jego P; Duhamel E; Provost K; dit Sollier CB; Presles E; Castellant P; Parent F; Salaun PY; Bressollette L; Nonent M; Lorillon P; Girard P; Lacut K; Guégan M; Bosson JL; Laporte S; Leroyer C; Décousus H; Meyer G; Mottier D;
    JAMA; 2015 Jul; 314(1):31-40. PubMed ID: 26151264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pulmonary embolism: Care standards in 2018.
    Borohovitz A; Weinberg MD; Weinberg I
    Prog Cardiovasc Dis; 2018; 60(6):613-621. PubMed ID: 29291427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary embolism: current and new treatment options.
    Walter RJ; Moores LK; Jiménez D
    Curr Med Res Opin; 2014 Oct; 30(10):1975-89. PubMed ID: 24983743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Anticoagulant treatment in pulmonary embolism : how to initiate and how to pursue ?].
    Greutert S; Robert-Ebadi H
    Rev Med Suisse; 2023 Dec; 19(853):2284-2289. PubMed ID: 38063446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombolysis for pulmonary embolism and venous thrombosis: is it worthwhile?
    Douma RA; Kamphuisen PW
    Semin Thromb Hemost; 2007 Nov; 33(8):821-8. PubMed ID: 18175288
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In-Hospital Management and Follow-Up Treatment of Venous Thromboembolism: Focus on New and Emerging Treatments.
    Lenchus JD; Biehl M; Cabrera J; Moraes AG; Dezfulian C
    J Intensive Care Med; 2017 Jun; 32(5):299-311. PubMed ID: 27179058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.